Hepatitis C infection among Dutch haemophilia patients: a nationwide cross-sectional study of prevalence and antiviral treatment. (Q45883324)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15876273%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

title

Hepatitis C infection among Dutch haemophilia patients: a nationwide cross-sectional study of prevalence and antiviral treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15876273%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

0 references

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15876273%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Johanna G van der Bom

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15876273%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

Posthouwer D

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15876273%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Plug I

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15876273%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Rosendaal FR

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15876273%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Mauser-Bunschoten EP

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15876273%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

publication date

1 May 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15876273%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15876273%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15876273%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15876273%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

270-275

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15876273%20AND%20SRC:MED&resulttype=core&format=json

The natural history and antiviral treatment of hepatitis C in haemophilia

11 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01083.X

Hemophilia complications. Hepatitis C infection and its management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01083.X

The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01083.X

The natural history of chronic hepatitis C in a cohort of HIV-negative Italian patients with hereditary bleeding disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01083.X

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01083.X

Health status and health-related quality of life associated with hemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01083.X

Side effects of therapy of hepatitis C and their management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01083.X

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01083.X

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01083.X

Thirty years of hemophilia treatment in the Netherlands, 1972-2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01083.X

Mortality in patients with hemophilia. Changes in a Dutch population from 1986 to 1992 and 1973 to 1986.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01083.X

Hepatitis C virus RNA in factor VIII concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01083.X

Diagnosis, management, and treatment of hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01083.X

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01083.X

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01083.X